Liver health and MASLD: a critical differentiator Both compounds reduce liver fat, but this is one area where the data is detailed enough to make meaningful comparisons
Dont Rush Your Dose Increases Many patients feel the urge to increase their dose quickly, but sticking at a lower dose for longer (especially if its working) can meaningfully reduce your monthly spend without affecting your results
By offering a new strategy for weight management, GLP-1 receptor agonists hold the potential to reduce the prevalence of obesity-related complications
Peptides have become the latest obsession on Instagram, TikTok, and YouTube, where influencers rave about injectable stacks that promise fat loss, faster recovery, better sleep, and glowing skin
We may speculate that a larger reduction of plasma aldosterone in the patients with advanced CKD seen in our study could be caused by a higher local activity of RAAS due to kidney dysfunction
Monumental as this approval would be, orforglipron isnt likely to completely overtake its competitors for several reasons